Clinical Trial Update: Exploring the Clinical Impact of MYC Aberrations and Their Relationship With Microenvironment in Diffuse Large B Cell Lymphoma and High-Grade B Cell Lymphoma

View source ↗

Summary

A recruiting clinical trial investigating how MYC aberrations and the tumor microenvironment affect diffuse large B-cell lymphoma and high-grade B-cell lymphoma…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• High-grade B-cell Lymphoma
• High-grade B-cell Lymphoma with Myc and Bcl2 Rearrangements
• High-grade B-cell Lymphoma with Myc and Bcl6 Rearrangements

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma | Status: RECRUITING